<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23379908</article-id>
      <article-id pub-id-type="pmc">3570399</article-id>
      <article-id pub-id-type="publisher-id">1746-1596-8-15</article-id>
      <article-id pub-id-type="doi">10.1186/1746-1596-8-15</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Eccrine carcinoma : a rare cutaneous neoplasm</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Idrissi Serhrouchni</surname>
            <given-names>Karima</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>idrissisehrouchni@yahoo.fr</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Harmouch</surname>
            <given-names>Taoufiq</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>taoufhar@yahoo.fr</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Chbani</surname>
            <given-names>Laila</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>chbanil@yahoo.fr</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>El Fatemi</surname>
            <given-names>Hind</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>hinde0012@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Sekal</surname>
            <given-names>Mohammed</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>doc.med@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Hammas</surname>
            <given-names>Nawal</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>nawal-h111@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Soughi</surname>
            <given-names>Meriem</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>msoughi@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Benchat</surname>
            <given-names>Loubna</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>loubnabenchat@yahoo.fr</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Amarti</surname>
            <given-names>Afaf</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>amartiafaf@gmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Pathology, Hassan II University Hospital, Fez, 30000, Morocco</aff>
      <aff id="I2"><label>2</label>Department of Dermatology, Hassan II University Hospital, Fez, 30000, Morocco</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>2</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <fpage>15</fpage>
      <lpage>15</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2013 Idrissi Serhrouchni et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Idrissi Serhrouchni et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.diagnosticpathology.org/content/8/1/15"/>
      <abstract>
        <p>Eccrine carcinoma is an extremely rare malignancy of the skin with few well documented cases reported in the literature. It is frequently found on the lower extremities, and it equally affects both sexes in the sixth and seventh decade.</p>
        <p>In our case, we present a 46- year-old female with a recurring exophytic tumor on the right lower extremity, without local extension.</p>
        <p>The initial tumor was biopsied, excised and diagnosed as an eccrine carcinoma.</p>
        <sec>
          <title>Virtual Slides</title>
          <p>The virtual slide(s) for this article can be found here: <ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/3568051328673318">http://www.diagnosticpathology.diagnomx.eu/vs/3568051328673318</ext-link>.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Eccrine carcinoma</kwd>
        <kwd>Sweat gland tumor</kwd>
        <kwd>Mammary gland</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Malignant cutaneous adnexal neoplasms are a large and varied group, in particular eccrine carcinoma. They are one of the most challenging areas of Dermatopathology
[<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>Eccrine and apocrine neoplasms present a bewildering array of morphologies which often defy precise classification
[<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>The purpose of this case is to discuss the most common problems concerning the classification of this rare neoplasm and report the aim of the immunohistochemical profiles in differential diagnosis between a primitive eccrine carcinoma of the skin and a secondary neoplasm.</p>
      <sec>
        <title>Case report</title>
        <p>In July 2012, a 45-year-old Moroccan woman presented to the department of Dermatology of Hassan II University Hospital of Fez with a 25-year-history of primary infertility, and an 18-month-history of an exophytic mass at the posterior right lower extremity, gradually increasing in size. She was otherwise healthy and had no systemic symptoms. Physical examination showed an ulcerative and bourgeoning mass of 15 cm with bleeding and purulent features (Figure
<xref ref-type="fig" rid="F1">1</xref>). Biological tests included a complete blood count, routine blood and urine chemistry were normal, except for elevated LDH. Tumor markers as like as CA 19&#x2013;9, CA 125, CA 15&#x2013;3 were normal. MRI of the leg showed a subcutaneous infiltrative process coming into contact with the muscle fascia.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Clinical picture showed an ulcerative and bourgeoning mass of 15 cm with bleeding and purulent features on the posterior right lower extremity.</p>
          </caption>
          <graphic xlink:href="1746-1596-8-15-1"/>
        </fig>
        <p>The rest of the radiological examination, including radiography of the lung, abdominopelvic ultrasonography, computed tomographic thoraco-abdomino-pelvic scan, was normal.</p>
        <p>The mammography and ultrasound examination objectified a 4 mm measuring benign cystic lesion of the left breast classified ACR 3, requiring supervision during six months.</p>
        <p>After biopsy of the lesion, a surgical excision with clear margins was performed.</p>
        <p>On gross examination, the tumor was 15 cm in size, bourgeoning, erythematous and heterogeneous with areas of necrosis and haemorrhage.</p>
        <p>Microscopic examination of the specimen revealed an undifferentiated malignant proliferation with nodular architecture, located in the deep dermis (Figure
<xref ref-type="fig" rid="F2">2</xref>). Tumor cells made clear cytoplasm with an hyperchromatic nucleus and a high mitotic activity (Figure
<xref ref-type="fig" rid="F3">3</xref>).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>An undifferentiated malignant proliferation with nodular architecture, located in the deep dermis (hematoxylin-eosin, original magnification: x 100).</p>
          </caption>
          <graphic xlink:href="1746-1596-8-15-2"/>
        </fig>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Tumor cells made clear cytoplasm with an hyperchromatic nucleus and a high mitotic activity (hematoxylin-eosin, original magnification: A, &#xD7; 200, B, x 400).</p>
          </caption>
          <graphic xlink:href="1746-1596-8-15-3"/>
        </fig>
        <p>Immunohistochemical analysis showed positive staining for cytokeratine and progesterone receptor. Cytokeratine 7 was weakly positive and Ki67 was estimated at 95% (Figure
<xref ref-type="fig" rid="F4">4</xref>).</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Immunohistochemical study showing reactivity for CK (A), CK7 (B) and progesterone receptors (C).</p>
          </caption>
          <graphic xlink:href="1746-1596-8-15-4"/>
        </fig>
        <p>In contrast, the tumor cells were not reactive to cytokeratine 20, estrogen receptor, LCA, CD10, S 100 protein, HMB45, desmin, H-caldesmon, CD 99, CD 117, CD 31 and CD 34.</p>
        <p>Based on these data, the diagnosis of primary cutaneous eccrine carcinoma was retained.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Eccrine glands are directly developed from the embryonic epidermis in the early months of fetal development
[<xref ref-type="bibr" rid="B1">1</xref>]. They are widely distributed almost everywhere on the skin
[<xref ref-type="bibr" rid="B2">2</xref>]. The topographic distribution of adnexal structures also offers insight into the logical classification of adnexal neoplasms
[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>Microscopy alone is insufficient to establish eccrine lineage neoplasm because there are none specific microscopic features
[<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Some problems are related to the classification of sweat gland carcinomas, which are currently classified on the basis of the corresponding classification of benign sweat gland adenoma
[<xref ref-type="bibr" rid="B5">5</xref>]. Such an approach, however, poses several problems; for example, (1) some carcinomas have no benign counterpart and do not fit the scheme (ductal carcinoma, adenoid cystic carcinoma, and mucinous carcinoma); (2) poorly differentiated carcinomas can be diagnosed only when a contiguous adenoma is found histologically; (3) histologic classification can be very complicated because adenomas are numerous and their classification is complex; and (4) terminology includes unusual and difficult terms, deriving from the terminology used for adenomas (malignant acrospiroma, porocarcinoma, hidradenocarcinoma, malignant cylindroma, malignant spiradenoma, and syringocystadenocarcinoma)
[<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>Recently, a classification of sweat gland carcinomas designed based on the classification of breast carcinomas has been tentatively proposed
[<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>Finally, recent studies have classified sweat gland carcinomas into eccrine and apocrine tumors
[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. In addition, no established authentic criteria are available for differentiation of an eccrine from an apocrine tumor
[<xref ref-type="bibr" rid="B10">10</xref>]. Moreover, both eccrine and apocrine forms seem to exist in some categories
[<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>].</p>
      <p>The correct identification of the origin of tumor is of utmost importance for the determination of appropriate therapy and prognosis. Immunohistochemistry has proved to be a useful adjunct for this purpose
[<xref ref-type="bibr" rid="B13">13</xref>].</p>
      <p>The cells in the excretory coil of eccrine gland sweat express positivity for low molecular weight keratin, epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA), as well as S100 protein in the basal layer only. The myoepithelial cell layer may be highlighted by smooth muscle actin (SMA), p63 and calponin. Acrosyringeal cells stain for high molecular weight keratin and cytokeratin 14. A subpopulation of cells also expresses positivity to bcl-2
[<xref ref-type="bibr" rid="B2">2</xref>]. Some eccrine carcinomas are positif to estrogen and progesterone receptors wich has an important clinical implications, as affected patients may be partially treated with hormonal therapy
[<xref ref-type="bibr" rid="B14">14</xref>]. The Ki-67 and p53 may be used to differentiate benign from malignant lesions
[<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <p>Clinically, eccrine carcinoma must be considered in the differential diagnosis of patients older than fifty years with long standing tumors in the limbs, including basal cell carcinoma (BCC), Paget&#x2019;s disease, melanoma, metastatic cancer
[<xref ref-type="bibr" rid="B16">16</xref>], inflammatory, lymphocytic and vascular lesions
[<xref ref-type="bibr" rid="B17">17</xref>].</p>
      <p>The histopathology of mucinous eccrine carcinoma of the skin is analogous to that of its counterpart in the breast. Consequently, it is sometimes difficult to exclude a metastatic disease
[<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. In a comparison between primary sweat gland tumors and metastatic breast carcinoma to skin, Busam et al.
[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B19">19</xref>] found that the use of antibodies against epidermal growth factor receptor strongly decorated 81% of sweat gland tumors, but only 17% of metastatic breast cancers (P=0.001). There was no significant difference between the skin tumors and metastatic breast carcinoma when antibodies against estrogen and progesterone receptors were used, but with progression of disease, androgen receptors (AR) are preserved with higher frequency than ER/PR in metastatic mammary carcinoma
[<xref ref-type="bibr" rid="B13">13</xref>]. In another study comparing benign, malignant primary eccrine and apocrine neoplasms to metastatic breast carcinoma, only 3.5% of these primary adnexal cancers demonstrated HER-2 positivity, whereas 10&#x2013;23% of the breast carcinomas were positive
[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. The authors suggested that this test may be useful in distinguishing primary skin cancers from metastatic breast cancers
[<xref ref-type="bibr" rid="B20">20</xref>]. Another study showed that primary cutaneous neoplasms stained strongly for p63 and CK 5/6 with high specificity, while CK 7 and 20 were not useful
[<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. When CK 7 was positive in the cutaneous lesions, it exhibited marked focality and a specific pattern, while metastatic breast carcinoma expressed CK 7 diffusely and did not express p63 or CK 5/6. The usefulness of CK 5/6 was again shown by Plumb et al.
[<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Ivan et al.
[<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B23">23</xref>] presented further evidence of the usefulness of p63 in the diagnosis of adnexal cancer; in their study, none of the examples of metastatic adenocarcinoma to skin stained for p63, whereas virtually all the adnexal carcinomas were positive.</p>
      <p>These studies showed that immunohistochemistry does not distinguish cutaneous eccrine tumours from cutaneous metastases of breast carcinoma, in which case clinical and radiological correlation is critical
[<xref ref-type="bibr" rid="B24">24</xref>].</p>
      <p>Other differential diagnoses comprise neoplasms with clear cell differentiation. These include trichilemmal carcinoma, clear cell BCC and clear cell carcinomas metastatic to the skin. With respect to the latter, the dominant diagnostic considerations are metastatic clear cell carcinoma from thyroid gland and lung. The expression of TTF seen in the great majority of these cases is helpful in resolving this dilemma. Some metastatic thyroid cancers also manifest expression of thyroglobulin. Metastatic clear cell carcinoma of renal primary origin manifests a prominent stromal vascularity with hemorrhage and areas of granular necrosis typically evident in biopsy material. Clear cell squamous cell carcinoma of the cervix is a glycogen-rich cancer with intercellular bridge formation characteristic of squamous differentiation
[<xref ref-type="bibr" rid="B15">15</xref>].</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>Eccrine carcinoma should be considered in the diagnosis of cutaneous malignant tumor with immunostaining for CK7, P63, CK5/6, estrogen and progesterone receptors.</p>
    </sec>
    <sec>
      <title>Consent from the patient</title>
      <p>Written informed consent was obtained from patient for publication of this case report.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>LDH: Lactate Dehydrogenase; MRI: Magnetic Resonance Imaging; ACR: American College of Radiology; CK: Cytokeratin; LCA: Leukocyte Common Antigen.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Montagna</surname>
            <given-names>W</given-names>
          </name>
          <article-title>Embryology and anatomy of the cutaneous adnexa</article-title>
          <source>J Cutan Pathol</source>
          <year>1984</year>
          <volume>11</volume>
          <fpage>350</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0560.1984.tb00391.x</pub-id>
          <pub-id pub-id-type="pmid">6512065</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nidal</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Khaled</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Danny</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Skin adnexal neoplasms: an approach to tumours of cutaneous sweat glands</article-title>
          <source>J Clin Pathol</source>
          <year>2007</year>
          <volume>60</volume>
          <fpage>145</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">16882695</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Timothy</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Calmont</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Batman and adnexal neoplasms</article-title>
          <source>J Cutan Pathol</source>
          <year>2010</year>
          <volume>37</volume>
          <fpage>401</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0560.2010.01525.x</pub-id>
          <pub-id pub-id-type="pmid">20377669</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brownstein</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Shapiro</surname>
            <given-names>L</given-names>
          </name>
          <article-title>The sweat gland adenomas</article-title>
          <source>Int J Dermatol</source>
          <year>1975</year>
          <volume>14</volume>
          <fpage>397</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-4362.1975.tb00130.x</pub-id>
          <pub-id pub-id-type="pmid">169204</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Carmelo</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Roberto</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Milena</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Adriana</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chiara</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Augusto</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Carcinomas of Sweat Glands</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2001</year>
          <volume>125</volume>
          <fpage>498</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="pmid">11260623</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cooper</surname>
            <given-names>PH</given-names>
          </name>
          <article-title>Carcinomas of sweat glands</article-title>
          <source>Pathol Annu</source>
          <year>1987</year>
          <volume>22</volume>
          <fpage>83</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">3033589</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Santa</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Sweat glands carcinomas: a comprehensive review</article-title>
          <source>Semin Diagn Pathol</source>
          <year>1987</year>
          <volume>4</volume>
          <fpage>38</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">2823361</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="book">
          <name>
            <surname>Murphy</surname>
            <given-names>GF</given-names>
          </name>
          <name>
            <surname>Elder</surname>
            <given-names>DE</given-names>
          </name>
          <source>Non-melanocytic Tumors of the Skin</source>
          <year>1991</year>
          <publisher-name>Washington, DC: Armed Forces Institute of Pathology</publisher-name>
          <fpage>61</fpage>
          <lpage>153</lpage>
          <comment>Atlas of Tumor Pathology; 3rd series, fascicle 1</comment>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="book">
          <name>
            <surname>Requena</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kiryu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ackerman</surname>
            <given-names>AB</given-names>
          </name>
          <source>Neoplasms With Apocrine Differentiation</source>
          <year>1998</year>
          <publisher-name>Philadelphia, Pa: Lippincott-Raven</publisher-name>
          <fpage>589</fpage>
          <lpage>855</lpage>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="book">
          <name>
            <surname>Abenoza</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ackerman</surname>
            <given-names>AB</given-names>
          </name>
          <source>Neoplasms With Eccrine Differentiation</source>
          <year>1990</year>
          <publisher-name>Philadelphia, Pa: Lea and Febiger</publisher-name>
          <fpage>371</fpage>
          <lpage>412</lpage>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Swanson</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Mazoujian</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mills</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Wick</surname>
            <given-names>MR</given-names>
          </name>
          <article-title>Immunoreactivity for estrogen receptor protein in sweat gland tumors</article-title>
          <source>Am J Surg Pathol</source>
          <year>1991</year>
          <volume>15</volume>
          <fpage>835</fpage>
          <lpage>841</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199109000-00003</pub-id>
          <pub-id pub-id-type="pmid">1951842</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ansai</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Koseki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hozumi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kondo</surname>
            <given-names>S</given-names>
          </name>
          <article-title>An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors: assessment of the specificity and sensitivity of markers of apocrine differentiation</article-title>
          <source>Am J Dermatopathol</source>
          <year>1995</year>
          <volume>17</volume>
          <fpage>249</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="doi">10.1097/00000372-199506000-00006</pub-id>
          <pub-id pub-id-type="pmid">8599433</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vinod</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Richard</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jinobya</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary</article-title>
          <source>Diagn Pathol</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>34</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-1-34</pub-id>
          <pub-id pub-id-type="pmid">17020615</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mirza</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Kloss</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sieber</surname>
            <given-names>SC</given-names>
          </name>
          <article-title>Malignant eccrine spiradenoma</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2002</year>
          <volume>126</volume>
          <fpage>591</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="pmid">11958666</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Crowson</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Magro</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Mihm</surname>
            <given-names>MC</given-names>
          </name>
          <article-title>Malignant adnexal neoplasms</article-title>
          <source>Mod Pathol</source>
          <year>2006</year>
          <volume>19</volume>
          <fpage>93</fpage>
          <lpage>126</lpage>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oliver</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ashraf</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bernard</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Armand</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nadeem</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Eccrine porocarcinoma of the lower extremity: a case report and review of literature</article-title>
          <source>World J Surg Oncol</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>94</fpage>
          <pub-id pub-id-type="doi">10.1186/1477-7819-9-94</pub-id>
          <pub-id pub-id-type="pmid">21859481</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Helena</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Ventura</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Orellana</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Novais</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Cheema</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Burnier</surname>
            <given-names>MN</given-names>
          </name>
          <article-title>Histopathological study of lesions of the caruncle: a 15-year single center review</article-title>
          <source>Diagn Pathol</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>29</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-4-29</pub-id>
          <pub-id pub-id-type="pmid">19719846</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="book">
          <name>
            <surname>Page</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Sakamoto</surname>
            <given-names>G</given-names>
          </name>
          <person-group person-group-type="editor">Page DL, Anderson TJ</person-group>
          <article-title>Infiltrating carcinoma: major histological types</article-title>
          <source>Diagnostic Histopathology of the Breast</source>
          <year>1987</year>
          <publisher-name>Churchill-Livingstone: New York</publisher-name>
          <fpage>193</fpage>
          <lpage>295</lpage>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Busam</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>LK</given-names>
          </name>
          <name>
            <surname>Granter</surname>
            <given-names>SR</given-names>
          </name>
          <article-title>Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas</article-title>
          <source>Mod Pathol</source>
          <year>1999</year>
          <volume>12</volume>
          <fpage>786</fpage>
          <lpage>793</lpage>
          <pub-id pub-id-type="pmid">10463481</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hiatt</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Pilow</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Smoller</surname>
            <given-names>BR</given-names>
          </name>
          <article-title>Her-2 expression in cutaneous eccrine and apocrine neoplasms</article-title>
          <source>Mod Pathol</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>28</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.3800007</pub-id>
          <pub-id pub-id-type="pmid">14631375</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Qureshi</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Ormsby</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>MW</given-names>
          </name>
          <article-title>The diagnostic utility of p63, CK5/6, CK 7, and Ck 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas</article-title>
          <source>Cutan Pathol</source>
          <year>2004</year>
          <volume>31</volume>
          <fpage>145</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="doi">10.1111/j.0303-6987.2004.00147.x</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Plumb</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Argenyi</surname>
            <given-names>ZB</given-names>
          </name>
          <name>
            <surname>Stone</surname>
            <given-names>MS</given-names>
          </name>
          <article-title>Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma</article-title>
          <source>Am J Dermatopathol</source>
          <year>2004</year>
          <volume>26</volume>
          <fpage>447</fpage>
          <lpage>451</lpage>
          <pub-id pub-id-type="doi">10.1097/00000372-200412000-00001</pub-id>
          <pub-id pub-id-type="pmid">15618924</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ivan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hafeez Diwan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Prieto</surname>
            <given-names>VG</given-names>
          </name>
          <article-title>Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin</article-title>
          <source>Mod Pathol</source>
          <year>2005</year>
          <volume>18</volume>
          <fpage>137</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.3800263</pub-id>
          <pub-id pub-id-type="pmid">15389254</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wallace</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Longacre</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Smoller</surname>
            <given-names>BR</given-names>
          </name>
          <article-title>Estrogen and progesterone receptors and anti&#x2010;gross cystic disease fluid protein 15 (BRST&#x2010;2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms</article-title>
          <source>Mod Pathol</source>
          <year>1995</year>
          <volume>8</volume>
          <fpage>897</fpage>
          <lpage>901</lpage>
          <pub-id pub-id-type="pmid">8751328</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
